Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GenPath Africa

Financiado

Cerrado

GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA

The overall goal of GenPath Africa is to control pathogen infections in Africa. Our consortium of African and European investigators proposes to build on our collective experience in responding to SARS-CoV-2 to better diagnose, mo... ver más

30/04/2027

SU UNIVERSITY OF S...

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

STELLENBOSCH UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-08-28

HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03: Genomic epidemiology for surveillan... ExpectedOutcome:Whilst 2021 has seen an unprecedented expansion in global genomic sequencing capacit...

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

SU UNIVERSITY OF STELLENBOSC...

2.08M€ | Lider

ILRI

1.00M€ | Participante

UANTWERPEN

999.50K€ | Participante

INS

421.13K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PANGenS Pan-Africa network for genomic surveillance of poverty relat... 5M€ Cerrado

CARE COMMON ACTION AGAINST HIV TB HCV ACROSS THE REGIONS OF EUROP... 3M€ Cerrado

EpiGen Ethiopia BUILDING SCALABLE PATHOGEN GENOMIC EPIDEMIOLOGY FOR ETHIOPIA 5M€ Cerrado

ODIN Strengthening Environmental Surveillance to Advance Public H... 5M€ Cerrado

APGREID Ancient Pathogen Genomics of Re Emerging Infectious Disease 1M€ Cerrado

SAF2017-82287-R CARACTERIZACION DEL VIROMA DE SANGRE MEDIANTE ULTRA-SECUENCI... 133K€ Cerrado

Duración del proyecto: 44 meses Fecha Inicio: 2023-08-28
Fecha Fin: 2027-04-30

Líder del proyecto

STELLENBOSCH UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 5M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The overall goal of GenPath Africa is to control pathogen infections in Africa. Our consortium of African and European investigators proposes to build on our collective experience in responding to SARS-CoV-2 to better diagnose, monitor and clinically manage current and future epidemics in Africa. We propose to expand genomics capacity to combat drug resistant HIV-1 and TB through precision medicine and by using genomic epidemiology to guide the public health response. GenPath Africa will also apply recent developments in wastewater and one health surveillance to detect emerging pathogens. Capacity development activities will include degree training in South Africa and the transfer of technology to the National Public Health Institute of Mozambique. The consortium’s objectives will be achieved by connecting the specialized genomics facilities of the Africa CDC Pathogen Genomics Initiative (Africa PGI) in South Africa and Kenya with African national public health institutes to translate scientific advances into public health actions. Long-term collaborations with Germany and Belgium will be leveraged to help achieve these objectives and make precision medicine and precision public health a reality in southern and East Africa. The consortium will also contribute to the long-term capacity building objectives of Africa PGI by contributing to harmonising training resources and collaboration with existing networks to ensure that all data are of high quality and available in public databases. GenPath Africa will advance the EDTCP3 work program by: i) providing researchers and public health professionals with skills in genomic epidemiology to better understand infectious disease epidemiology and drug resistance, ii) strengthening capability in southern and East Africa to rapidly respond to current and emerging epidemics, and iii) providing researchers with training to advance their scientific careers in Africa and establish themselves as scientific and public health leaders.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores